* 출처 : 서울아산병원
제13회 GIST환우 모임
2016년 5월 28일 / 서울아산병원 대강당
서울아산병원 종양내과
류민희 교수
진료과: 종양내과,간센터,간암센터,위암센터
전문진료분야: 위암,간암,GIST,소화기육종
교육 및 연구 경력
현)울산의대 서울아산병원 종양내과 부교수
학력 사항
서울대학교 의학 학사
서울대학교 의학 석사
울산대학교 의학 박사
주요 업적
<논문>
A potential pitfall in evaluating HER2 immunohistochemistry for gastric signet ring cell carcinomas.
Asian Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Stromal Tumor.
Association of nutritional status-related indices and chemotherapy-induced adverse events in gastric cancer patients.
Efficacy and Safety of Regorafenib in Korean Patients with Advanced Gastrointestinal Stromal Tumor After Failure of Imatinib and Sunitinib: A Multicenter Study Based on the Management Access Program.
Impact of imatinib rechallenge on health-related quality of life in patients with TKI-refractory gastrointestinal stromal tumours: Sub-analysis of the placebo-controlled, randomised phase III trial (RIGHT).
Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus.
Over-the-wire versus through-the-scope stents for the palliation of malignant gastric outlet obstruction: A retrospective comparison study.
Prognostic impact of fibroblast growth factor receptor 2 gene amplification in patients receiving fluoropyrimidine and platinum chemotherapy for metastatic and locally advanced unresectable gastric cancers.
Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinoma.
Second-Line Irinotecan, Leucovorin, and 5-Fluorouracil for Gastric Cancer Patients after Failed Docetaxel and S-1.
